Zymeworks (ZYME) Tax Provisions (2021 - 2026)
Zymeworks recorded quarterly Tax Provisions of -$2.2 million in Q1 2026, down 711.48% quarter-over-quarter from -$270000.0 in Q4 2025, and down 541.73% year-over-year from $496000.0 in Q1 2025.
Zymeworks' Tax Provisions history runs 6 years deep, the most recent figure standing at -$2.2 million for Q1 2026.
- In Q1 2026, Tax Provisions fell 541.73% year-over-year to -$2.2 million; the TTM figure through Mar 2026 stood at -$1.3 million (down 120.15% YoY), while the FY2025 annual figure was $1.4 million, down 77.38% from the prior year.
- Tax Provisions came in at -$2.2 million for Q1 2026 at Zymeworks, down from -$270000.0 in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $11.0 million in Q4 2022 to a low of -$4.7 million in Q4 2023.
- A 5-year average of $917294.1 and a median of $75000.0 in 2024 frame the typical range for Tax Provisions.
- Across the five-year window, Tax Provisions jumped 18477.78% in 2023 and sank 541.73% in 2026, its largest moves.
- Zymeworks' Tax Provisions stood at $11.0 million in 2022, then plunged by 142.91% to -$4.7 million in 2023, then jumped by 221.03% to $5.7 million in 2024, then slumped by 104.72% to -$270000.0 in 2025, then slumped by 711.48% to -$2.2 million in 2026.
- According to Business Quant data, Tax Provisions over the past three periods registered -$2.2 million, -$270000.0, and $1.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -11.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -859,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 221.50 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 216,000.00 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 104.00 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 15.66 Mn |
| 10 | Zymeworks | 1.84 Bn | 1.47 Bn | - | -2.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.19 Mn |
| Dec 31, 2025 | -270,000.00 |
| Sep 30, 2025 | 1.34 Mn |
| Jun 30, 2025 | -186,000.00 |
| Mar 31, 2025 | 496,000.00 |
| Dec 31, 2024 | 5.72 Mn |
| Sep 30, 2024 | 226,000.00 |
| Jun 30, 2024 | 68,000.00 |
| Mar 31, 2024 | 75,000.00 |
| Dec 31, 2023 | -4.72 Mn |
| Sep 30, 2023 | 1.11 Mn |
| Jun 30, 2023 | 1.65 Mn |
| Mar 31, 2023 | 1.39 Mn |
| Dec 31, 2022 | 11.01 Mn |
| Sep 30, 2022 | -29,000.00 |
| Jun 30, 2022 | -9,000.00 |
| Mar 31, 2022 | -74,000.00 |
| Dec 31, 2021 | -1.37 Mn |
| Sep 30, 2021 | 764,000.00 |